Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Neuroscience Letters|June 19, 2021
The endocannabinoid system as a therapeutic target for schizophrenia: Failures and potentialsAlexandre SeillierExperimental Brain Research|March 15, 2024
Inhibition of fatty acid amide hydrolase reverses aberrant prefrontal gamma oscillations in the sub-chronic PCP model for schizophreniaAlexandre SeillierPharmacology, Biochemistry, and Behavior|March 23, 2011
Inhibition of fatty acid amide hydrolase modulates anxiety-like behavior in PCP-treated ratsAlexandre Seillier, Andrea GiuffridaEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 27, 2015
Disruption of social cognition in the sub-chronic PCP rat model of schizophrenia: Possible involvement of the endocannabinoid systemAlexandre Seillier, Andrea GiuffridaProgress in Neuro-Psychopharmacology & Biological Psychiatry|April 24, 2012
New insights on endocannabinoid transmission in psychomotor disordersAndrea Giuffrida, Alexandre SeillierBehavioural Brain Research|September 1, 2009
Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801Alexandre Seillier, Andrea GiuffridaNeuropharmacology|November 25, 2017
The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further evidence for transporter-mediated endocannabinoid releaseAlexandre Seillier, Andrea GiuffridaBehavioural Pharmacology|July 14, 2017
Anxiety does not contribute to social withdrawal in the subchronic phencyclidine rat model of schizophreniaAlexandre Seillier, Andrea GiuffridaNeuroscience Research|April 20, 2016
Distinct neuronal activation patterns are associated with PCP-induced social withdrawal and its reversal by the endocannabinoid-enhancing drug URB597Julien Matricon, Alexandre Seillier, Andrea GiuffridaNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 9, 2013
Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB₁ receptors: implications for schizophreniaAlexandre Seillier, Alex A Martinez, Andrea GiuffridaPageof 3